The Federal Trade Commission has approved a motion granting Chairman Andrew Ferguson the authority to comply with President ...

(Reuters) - U.S. Federal Trade Commission Chair Andrew Ferguson gained broad authority to purge diversity, equity and ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

New FTC Chair Andrew Ferguson is closing the agency’s Office of Workplace Inclusivity and Opportunity and placing all its ...

In recent decades, Republicans defined themselves as the party of free trade. Trump-era policies have challenged this ...

Dozens of employees across the government described agencies gripped with uncertainty about how to implement the new policies ...

Returning US President Donald Trump has made the art of the deal his trademark. The immediate future looks promising for the ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The director of the Consumer Financial Protection Bureau, Rohit Chopra, has been waiting for a phone call, letter, email, text — anything, really — from the Trump administration to say if he’s getting ...

asked the commission on Thursday to grant him authority to strip all mention of DEI from FTC documents after President Donald Trump's executive order banning such programs in the federal government.